Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Runben Biotechnology CoSHSE:603193 -1.79%72 Interest Coverage is 4,340.67 as of Mar. 2026, which is 343% above its 10-year median of 980.65. GuruFocus rates SHSE:603193 with a GF Score™ of 72/100 and a GF Value™ of ¥28.24 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 1,512 Consumer Packaged Goods companies, Runben Biotechnology Co ranks better than 95.97% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Runben Biotechnology Co's
Operating Income
for the
three
months ended in Mar. 2026 was ¥52 Mil. Runben Biotechnology Co's Interest Expense for the
three
months ended in Mar. 2026 was ¥-0 Mil.
Runben Biotechnology Co's interest coverage for the quarter that ended in Mar. 2026 was 4,340.67.
The higher the ratio, the stronger the company's financial strength is.
Good Sign:
Ben Graham prefers companies' interest coverage to be at least 5. Runben Biotechnology Co Ltd has enough cash to cover all of its debt. Its financial situation is stable.
The historical rank and industry rank for Runben Biotechnology Co's Interest Coverage or its related term are showing as below:
SHSE:603193'
s Interest Coverage Range Over the Past 10 Years
Min: 27.16 Med: 980.65 Max: 5018.35
Current: 5018.35
SHSE:603193's Interest Coverage is ranked better than 95.97% of 1512
companies
in the Consumer Packaged Goods industry
Industry Median: 8.6
vs SHSE:603193: 5018.35
Runben Biotechnology Co (SHSE:603193) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Runben Biotechnology Co Interest Coverage Related Terms
Runben Biotechnology Co Interest Coverage Historical Data
* Premium members only.
The historical data trend for Runben Biotechnology Co's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
SHSE:603193 vs PG, CL, KVUE: Interest Coverage Comparison
For the Household & Personal Products subindustry, Runben Biotechnology Co's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Runben Biotechnology Co Interest Coverage vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Runben Biotechnology Co's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Runben Biotechnology Co's Interest Coverage falls into.
Runben Biotechnology Co Interest Coverage Calculation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Runben Biotechnology Co (SHSE:603193) has a Interest Coverage of 4,340.67 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Runben Biotechnology Co and its competitors. This is 343% above median its historical median of 980.65. Over the past decade, Runben Biotechnology Co's Interest Coverage has ranged from 27.16 to 5,018.35. According to the industry distribution chart, Runben Biotechnology Co ranks #61 out of 1512 companies in the Consumer Packaged Goods industry, placing it in the top 4%.
Is Runben Biotechnology Co's Interest Coverage too high?
Runben Biotechnology Co's current Interest Coverage of 4,340.67 is 343% above median its 10-year median of 980.65. Over the past 10 years, this metric has ranged from a low of 27.16 to a high of 5,018.35. The Consumer Packaged Goods industry median Interest Coverage is 8.60. Runben Biotechnology Co's value of 4,340.67 is 50372.9% above this industry median. Based on the distribution chart, Runben Biotechnology Co ranks #61 out of 1512 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, Runben Biotechnology Co has a GF Score™ of 72/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Runben Biotechnology Co's Interest Coverage compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Runben Biotechnology Co ranks #61 out of 1512 companies for Interest Coverage. This places Runben Biotechnology Co in the top 4% of its industry — outperforming the majority of peers. The industry median Interest Coverage is 8.60. Runben Biotechnology Co's value of 4,340.67 is 50372.9% above this benchmark. Historically, Runben Biotechnology Co's own Interest Coverage has ranged from 27.16 to 5,018.35 over the past decade. While the company's 10-year median is 980.65 vs. the industry median of 8.60, Runben Biotechnology Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Consumer Packaged Goods company?
The median Interest Coverage among Consumer Packaged Goods companies is 8.60, based on 1,512 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Runben Biotechnology Co's current Interest Coverage of 4,340.67 is 50372.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Runben Biotechnology Co and its competitors. For the Consumer Packaged Goods industry, the median Interest Coverage is 8.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Runben Biotechnology Co's current Interest Coverage is 4,340.67, which is 343% above median its own 10-year median of 980.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Runben Biotechnology Co stock overvalued right now?
Based on GuruFocus' analysis, Runben Biotechnology Co (SHSE:603193) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥28.24, compared to a current price of ¥21.96 — trading 22.2% below its estimated fair value. The current Interest Coverage is 4,340.67, which is 343% above median its 10-year median of 980.65 and 50372.9% above the Consumer Packaged Goods industry median of 8.60. Runben Biotechnology Co's overall GF Score™ is 72/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Runben Biotechnology Co (SHSE:603193), the current Interest Coverage is 4,340.67 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Runben Biotechnology Co (SHSE:603193) Overvalued in 2026?
Based on GuruFocus' analysis, Runben Biotechnology Co stock appears to be undervalued.
The current stock price of ¥21.96 is trading 22.2% below its estimated GF Value™ of ¥28.24.
GuruFocus considers Runben Biotechnology Co to be Modestly Undervalued.
Key valuation signals for SHSE:603193:
Interest Coverage: 4,340.67 (343% above median its 10-year median of 980.65)
GF Value™: ¥28.24 vs. price of ¥21.96 (22.2% below fair value)
Industry Position: 50372.9% above the Consumer Packaged Goods median (#61 of 1512)
No single metric tells the full story. See the SHSE:603193 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603193 has been successfully added to your 
